海通国际发布可孚医疗研报：单三季度高速增长，健耳听力大幅减亏

Group 1 - Haitong International issued a report on November 12, giving KeFu Medical (301087.SZ, latest price: 44.5 CNY) an "outperform" rating with a target price of 53.84 CNY [1] - The rating rationale includes significant reduction in losses from the hearing aid business, which is expected to contribute to profits [1] - The international business is steadily improving, indicating potential for growth [1]